HYDROXYCHLOROQUINE REDUCES BINDING OF ANTIPHOSPHOLIPID ANTIBODIES TO SYNCYTIOTROPHOBLASTS AND RESTORES ANNEXIN A5 EXPRESSION

Por Wu, Xiao-Xuan, Guller, Seth, Rand, Jacob H.
Publicado em 2011

Insights into the Pathophysiology of the Antiphospholipid Syndrome Provided by Atomic Force Microscopy

Por Quinn, Anthony S., Wu, Xiao-Xuan, Rand, Jacob H., Taatjes, Douglas J.
Publicado em 2012

A novel, rapid method to compare the therapeutic windows of oral anticoagulants using the Hill coefficient

Por Chang, Jeremy B., Quinnies, Kayla M., Realubit, Ronald, Karan, Charles, Rand, Jacob H., Tatonetti, Nicholas P.
Publicado no Sci Rep (2016)

Imaging aspects of cardiovascular disease at the cell and molecular level

Por Taatjes, Douglas J., Wadsworth, Marilyn P., Quinn, Anthony S., Rand, Jacob H., Bovill, Edwin G., Sobel, Burton E.
Publicado em 2008

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers

Por Rand, Jacob H., Wu, Xiao-Xuan, Quinn, Anthony S., Chen, Pojen P., Hathcock, James J., Taatjes, Douglas J.
Publicado em 2008

Annexin A5 Binds to Lipopolysaccharide and Reduces Its Endotoxin Activity

Por Rand, Jacob H., Wu, Xiao-Xuan, Lin, Elaine Y., Griffel, Alexander, Gialanella, Philip, McKitrick, John C.
Publicado em 2012

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

Por Posch, Florian, Gebhart, Johanna, Rand, Jacob H., Koder, Silvia, Quehenberger, Peter, Pengo, Vittorio, Ay, Cihan, Pabinger, Ingrid
Publicado no BMC Med (2017)

ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura

Por Tsai, Han-Mou, Raoufi, Mojgan, Zhou, Wenhua, Guinto, Enriqueta, Grafos, Nickolas, Ranzurmal, Safi, Greenfield, Robert S., Rand, Jacob H.
Publicado em 2006

Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I

Por Wahezi, Dawn M., Ilowite, Norman T., Wu, Xiao Xuan, Pelkmans, Leonie, de Laat, Bas, Schanberg, Laura E., Rand, Jacob H.
Publicado em 2013

Human Monoclonal Antiphospholipid Antibodies Disrupt the Annexin A5 Anticoagulant Crystal Shield on Phospholipid Bilayers: Evidence from Atomic Force Microscopy and Functional Assa...

Por Rand, Jacob H., Wu, Xiao-Xuan, Quinn, Anthony S., Chen, Pojen P., McCrae, Keith R., Bovill, Edwin G., Taatjes, Douglas J.
Publicado em 2003

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

Por Rand, Jacob H., Wu, Xiao-Xuan, Quinn, Anthony S., Ashton, Anthony W., Chen, Pojen P., Hathcock, James J., Andree, Harry A. M., Taatjes, Douglas J.
Publicado em 2010

Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older Persons

Por Arvanitakis, Zoe, Brey, Robin L., Rand, Jacob H., Schneider, Julie A., Capuano, Ana W., Yu, Lei, Leurgans, Sue E., Bennett, David A., Levine, Steven R.
Publicado no Circulation (2014)

Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging (ABICMA): Design of a Community-based, Longitudinal, Clinical-pathological Study

Por Arvanitakis, Zoe, Brey, Robin L., Rand, Jacob H., Schneider, Julie A., Leurgans, Sue E., Yu, Lei, Buchman, Aron S., Arfanakis, Konstantinos, Fleischman, Debra A., Boyle, Patricia A., Bennett, David A., Levine, Steven R.
Publicado em 2012